Most digital health founders hit the same wall: how do you build a product that patients love, providers use, and payers reimburse?

Steven Coen, CEO and co-founder of SaRA Health, figured it out. Their platform helps patients stay connected between visits, keeps providers engaged, and, crucially, makes it all billable under existing CPT codes.

In this Q&A, Steven shares how he cracked the reimbursement puzzle, why “margin per episode” beats revenue every time, and what the future means for healthtech founders.

For years, digital health was about revolution. The first wave of companies didn’t want to play by healthcare’s rules—they wanted to rewrite them.

Their pitch was simple: We’ll engage your employees, improve outcomes, and save you money by reducing high-cost care events. This model gave us some of the biggest names in digital health: Omada Health, Livongo, Hinge Health.

And to be fair—they succeeded. Eventually. But it wasn’t easy. These companies fought long sales cycles, tough ROI conversations, and now, years later, they’ve earned their place as leaders.

At 3L, we invest in companies shifting healthcare from reactive treatment to proactive prevention. Denti.AI's platform identifies issues months earlier while making preventive care workflows efficient and profitable.

Our latest deep dive by Yulie Klerman examines how Novo’s supply constraints, steep pricing, and a uniquely American regulatory loophole sparked a telehealth gold rush, opening the door for Lilly to dominate the market it didn’t even enter first.

Why this matters: At 3L, we help founders avoid these exact GTM pitfalls. Strategy isn’t just messaging - it’s knowing how regulation, policy, incentives, and behavior collide in the real world.

Today, we're thrilled to feature Lynn Shapiro Snyder, a true pioneer in healthcare law who has been at the forefront of healthcare policy for over four decades. Lynn is a senior healthcare regulatory and AI compliance lawyer at Epstein Becker Green in Washington, D.C., where she's helped draft foundational healthcare legislation, including Medicare's prospective payment system.

Today, we're thrilled to feature Sara Ratner, President of Integrated Programs at Nomi Health, whose career spans the legal and compliance side at CVS Caremark through executive roles at companies like RedBrick Health and NeoPath Health, to founding her own company, Proximal Health.

In this Q&A, Sara shares insights on healthcare innovation, government partnerships, and the future of healthtech.

By Elena Sterlin

We're excited to launch this series with Phoebe L. Yang, a board director on a number of private and public healthcare company boards and former General Manager of Amazon Web Services Healthcare, where she led cloud platforms to achieve 70% year-over-year growth. Her career uniquely combines deep healthcare operational experience with technology leadership and government service across two presidential administrations.

By Lena Rogovin

3L's Lena Rogovin recently shared her insights on the future of health insurance and longevity during the mHealth LIVE webinar, "The Business of Healthy Aging." The blog below showcases themes from her webinar remarks.

By Elena Sterlin

As global VC funding tightens, the UK is charting a distinctive course—one that favors capital discipline, strategic clarity, and sector strength.

3L’s Founder, Elena Sterlin, had the opportunity to attend the Carta Spring Summit in London, where a mix of founders, investors, and LPs gathered to unpack what’s happening in venture markets—and where we go from here.

By Lena Rogovin

Lena Rogovin attended MIXiii Health-Tech.IL in Jerusalem, where she engaged with leaders at the forefront of AI and digital health. The discussions underscored AI’s transformative impact on healthcare while also highlighting the critical challenges that remain—particularly in clinical adoption.

By Yulie Klerman

San Francisco welcomed J.P. Morgan Healthcare Conference attendees this year with a rare sight: warm, sunny weather. After the dampened spirits of past years—thanks to the pandemic and two conferences soaked in literal and metaphorical rain—the city felt alive again.

By Elena Sterlin

From AI-driven mental health platforms to revolutionary predictive analytics solutions, Tel Aviv's 700+ digital health startups are shaping the future of healthcare. With over $800M raised in 2024 and 53 new digital health startups founded in the past two years, Israel continues to cement its position as a global health tech innovation hub.

By Elena Sterlin for The World Economic Forum’s Centre for Health and Healthcare.

In 2021 alone, global spending on health reached a staggering $9.8 trillion, accounting for 10.3% of global GDP.

By EIena Sterlin

In a world where poor health is becoming more prevalent, health and life insurance companies may be the key to providing tangible solutions.

By Nick Herbert for Investors in Healthcare

Africa represents 11% of the world’s population, but over 24% of the global disease burden. Today, the continent’s US$21bn private healthcare market provides about 50% of care needs but provision is highly fragmented and most payments for health services are out of pocket.

2025 marked a turning point for 3L. What began in mid-2024 as a thesis—that the future of healthcare lies in prevention rather than treatment—translated into tangible results: six investments, including four this year, our first successful exit, and an expanded presence across Israeli and US healthtech ecosystems.

From investing in AI-enabled platforms that simplify elderly care navigation and scale dental consolidation, to hosting expert-led workshops focused on sharpening go-to-market (GTM) strategy, this quarter emphasized that clarity is the new currency of digital health.

From our latest investment in social health to expert insights on AI, government programs, and trust in healthcare, this quarter underscored how strong fundamentals, regulatory shifts, and human connection are shaping the future of care.

We’re breaking down the biggest trends in digital health—from surging investor interest in MSK solutions to Israel’s expanding health tech influence and lessons from 23andMe’s struggles. Don’t miss our insights on what’s shaping healthcare in 2025!